Annika Soderbergh
Örebro University
3 Papers
10 Citations
Annika Soderbergh is an academic researcher from Örebro University. The author has contributed to research in topics: Randomized controlled trial & Certolizumab pegol. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial
Merete Lund Hetland,Espen A Haavardsholm,Anna Rudin,Dan Nordström,M. T. Nurmohamed,Bjorn Gudbjornsson,Jon Lampa,Kim Hørslev-Petersen,Till Uhlig,Gerdur Gröndal,Mikkel Østergaard,Marte Schrumpf Heiberg,Jos W. R. Twisk,Kristina Lend,Simon Krabbe,Lise Hyldstrup,Joakim Lindqvist,Anna-Karin H. Ekwall,Kathrine Lederballe Grøn,Meliha C Kapetanovic,F. Faustini,Riitta Tuompo,Tove Lorenzen,Giovanni Cagnotto,Eva Baecklund,Oliver Hendricks,Daisy Vedder,T. Sokka-Isler,Tomas Husmark,Maud Kristine Aga Ljoså,Eli Brodin,Torkell Ellingsen,Annika Soderbergh,Milad Rizk,Åsa Reckner Olsson,Per Larsson,Line Uhrenholt,Søren Andreas Just,David John Stevens,Trine Bay Laurberg,Gunnstein Bakland,Inge C. Olsen,Ronald F van Vollenhoven,Ronald F van Vollenhoven +43 more
TL;DR: The results highlight the efficacy and safety of active conventional treatment based on methotrexate combined with corticosteroids and certification pegol and tocilizumab, but not to abatacept, and show no major differences among the four treatments.
83
A multicenter randomized study in early rheumatoid arthritis to compare active conventional therapy versus three biological treatments: 24 week efficacy results of the nord-star trial
M.L. Hetland,Espen A Haavardsholm,Anna Rudin,Dan Nordström,Michael T. Nurmohamed,Bjorn Gudbjornsson,Jon Lampa,Kim Hørslev-Petersen,T. Uhlig,Gerdur Gröndal,Mikkel Ǿstergaard,Marte Schrumpf Heiberg,Jos W. R. Twisk,Simon Krabbe,Kristina Lend,Inge C. Olsen,Joakim Lindqvist,Anna-Karin H. Ekwall,Kathrine Lederballe Grøn,Meliha C Kapetanovic,F. Faustini,Riitta Tuompo,Tove Lorenzen,Giovanni Cagnotto,Eva Baecklund,Oliver Hendricks,Daisy Vedder,T. Sokka-Isler,Tomas Husmark,Maud-Kristine Aga Ljosa,Eli Brodin,Torkell Ellingsen,Annika Soderbergh,Milad Rizk,Å. Reckner,Per Larsson,Line Uhrenholt,Søren Andreas Just,David John Stevens,Trine Bay Laurberg,Gunnstein Bakland,R. van Vollenhoven +41 more
TL;DR: Gudbjornsson et al. as mentioned in this paper found that ACT was non-inferior to CZP and TCZ, but not to ABA, with the predefined 15% margin remaining within the pre-defined noninference margin versus ACT.
8
•Journal Article
A Multicenter Randomized Study in Early Rheumatoid Arthritis to Compare Active Conventional Therapy versus Three Biological Treatments: 24 Week Efficacy and Safety Results of the NORD-STAR Trial
Merete Lund Hetland,Espen A Haavardsholm,Anna Rudin,Dan Nordström,Michael T. Nurmohamed,Bjorn Gudbjornsson,Jon Lampa,Kim Hørslev-Petersen,Till Uhlig,Gerdur Grondal,Mikkel Østergaard,Marte Schrumpf Heiberg,Jos W. R. Twisk,Kristina Lend,Simon Krabbe,Joakim Lindqvist,Anna-Karin H. Ekwall,Kathrine Lederballe Grøn,Meliha C Kapetanovic,Francesca Faustini,Riitta Tuompo,Tove Lorenzen,Giovanni Cagnotto,Eva Baecklund,Oliver Hendricks,Daisy Vedder,T. Sokka-Isler,Tomas Husmark,Maud-Kristine Aga Ljosa,Eli Brodin,Torkell Ellingsen,Annika Soderbergh,Milad Rizk,Asa Reckner,Line Uhrenholt,Per Larsson,Soeren Just,David John Stevens,Trine Bay Laurberg,Gunnstein Bakland,Inge C. Olsen,Ronald F van Vollenhoven +41 more
TL;DR: High remission rates were found across all four treatment arms at 24 wks, which underscores the efficacy of active conventional therapy based on MTX combined with glucocorticoids and may guide future treatment strategies for early RA.
4